Latest News

Wall Street weighs prospect of an AI slowdown on data center buildout
Infrastructure and energy companies invested in the AI buildout face a potential slowdown. "Any significant delay could cost them," an investor told CNBC.

Oil's next test: Saudi Arabia races to restore a key safety valve for prices
Saudi Arabia's closure of the East-West pipeline has put more than 4 million barrels a day of crude export capacity at risk, forcing additional volumes toward the Strait of Hormuz. Analysts warn oil p

NPFD: Discount Remains Unappealing And In The Wrong Environment
Nuveen Variable Rate Preferred & Income Fund remains a 'Hold' as rate sensitivity and a modest discount limit appeal. Despite its name, NPFD is mostly fixed-to-fixed rate preferreds, resulting in a le

Zevra Therapeutics, Inc. (ZVRA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Zevra Therapeutics, Inc. (ZVRA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Thor Industries Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
THOR Industries, Inc. (NYSE:THO) will release earnings for its fourth quarter before the opening bell on Tuesday, Sept. 22.

UnitedHealth: Lagging, But An Upbeat 2026 Outlook Helps Clear The Path
UnitedHealth Group (UNH) remains a buy, with attractive valuation and solid fundamentals despite recent underperformance versus the S&P 500. Q2 results delivered an earnings triple play: beats on reve

Ready Capital Series E Preferred Shares: Don't Be A Hero
Ready Capital is a deeply distressed CRE REIT with 37% of its portfolio in non-performing loans. RC's preferred shares (RC.PR.E) trade at 50 cents on the dollar, reflecting severe impairment risk and

Crescent Biopharma, Inc. (CBIO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Crescent Biopharma, Inc. (CBIO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

IonQ: Significant Revenue Growth Ahead As Tech Stack Scales
IonQ is a leading quantum computing firm, poised to more than double full-year revenues amid rapid market evolution. IONQ's quantum solutions are integrated into major cloud platforms, targeting enter

Dave & Buster's Entertainment, Forgent Power Solutions And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Chewy Eyes Pet Health, AI and Clinics to Drive Its Next Growth Phase
Chewy NYSE: CHWY is prioritizing U.S. health services, customer spending expansion and artificial intelligence capabilities as it seeks to build on its pet retail foundation, Chief Executive Officer S

OpenAI has tapped a startup to make its AI work for lawyers
OpenAI wants more lawyers to use its AI. To that end, it's partnered with a new startup to give it boots on the ground inside law firms.

What to watch as Treasury Secretary Scott Bessent testifies before Congress
Treasury Secretary Scott Bessent's testimony before the House Financial Services Committee is formally focused on the international financial system and the IMF, but lawmakers are expected to question

Arizona Eagle Mining Corp. Announces Sampling Results on Recently Acquired Silver Mine Claims
Toronto, Ontario--(Newsfile Corp. - September 15, 2026) - Arizona Eagle Mining Corp. (TSXV: AZEM) (OTCQB: AZEMF) (the "Company" or "Arizona Eagle") is pleased to announce results of a recent surface s

Zefiro Awarded Three Federally Funded Well Plugging Projects in Ohio and Pennsylvania
Zefiro was Sole Bidder on Two of Three Awards; Combined Value of Contracts is Approximately US$1.9 Million Bradford, Pennsylvania--(Newsfile Corp. - September 15, 2026) - Zefiro Methane Corp. (CBOE CA

Sabra Health Care REIT: This 5.85% Healthcare REIT Is Undervalued
Sabra Health Care REIT is rated 'Buy' with a $24.50/share price target, reflecting undervaluation and strong fundamentals. SBRA reported robust Q2 results: 24.7% revenue growth, 13.7% same-store manag

Arista Networks: AI Networking And EOS Drive Multi-Year Growth
I rate Arista Networks a Buy, supported by robust AI networking demand, campus/enterprise expansion, and competitive differentiation via EOS and CloudVision platforms. AI networking is expanding into

American Tower: Why I'm Buying A Wide Moat REIT At A Decade High Yield
American Tower is rated a Strong Buy, trading near 52-week lows with a dividend yield close to a decade high. AMT's resilient business model, long-term leases, and growing data center segment underpin

VYMI: $32 Billion Left U.S. Funds, And Its Biggest Risk Is Now An Edge
Vanguard International High Dividend Yield ETF is a buy at $105.60, despite a 19.7% YTD gain, due to robust financials exposure. VYMI's 43.6% allocation to financials aligns with rising global rates a

LVHD: Underperformance Likely To Continue Into 2027 As Low Beta Restrains Upside, A Hold
I maintain the Hold rating on the Franklin U.S. Low Volatility High Dividend Index ETF, which reflects my skeptical stance on the low beta/value combination. LVHD's low volatility and value approach o